Severe Refractory Hypocalcemia After Administering Zoledronic Acid for Osteoporotic Fracture in Primary Hyperparathyroidism That Is Complicated Into Hungry Bone Syndrome: A Case Report

Zoledronic acid is a very effective (IV) amino bisphosphonate which is indicated in osteoporosis, hypercalcemia of malignancy, multiple myeloma, Paget’s disease, and bone metastases from solid tumors. Bisphosphonate inhibits bone resorption through actions on osteoclast activity resulting in increas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Alhamdan, Ali Saleh, Douba, Najah Younes, Aljamaan, Abdulaziz, Alghamdi, Abdulrahman Aidh, Alhammad, Zahrah Abbas, Alanazi, Khalid
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Bone and Mineral Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089785/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.450
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars